Thomas Braxton King, President & CEO at Alexza Pharmaceuticals Inc. (ALXA), bought 64,655 shares at $2.32 ($150K) on 2009-10-05, disclosed to the SEC on 2009-10-06.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ALXA | SELL | 2012-08-29 | $41K | — | Filing → |
| ALXA | SELL | 2012-06-08 | $22K | — | Filing → |
| ALXA | SELL | 2009-12-21 | $100K | — | Filing → |